Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (151-160 of 200) with videos related to

Pageof 20
Sort By:
Annals of Internal Medicine|July 21, 2020
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized TrialMaurizio Menichelli, Franz-Josef Neumann, Gjin Ndrepepa, et al.
European Heart Journal|October 26, 2018
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolismChristian Pristipino, Horst Sievert, Fabrizio D'Ascenzo, et al.
International Journal of Cardiology. Heart & Vasculature|July 14, 2021
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stentingLisa Riesinger, Claudia Strobl, David M Leistner, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 25, 2018
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolismChristian Pristipino, Horst Sievert, Fabrizio D'Ascenzo, et al.
Journal of the American College of Cardiology|March 7, 2015
Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart diseaseKimon Stamatelopoulos, Dirk Sibbing, Loukianos S Rallidis, et al.
Thrombosis and Haemostasis|November 28, 2022
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesTobias Koch, Shqipdona Lahu, J J Coughlan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 28, 2021
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditionsChristian Pristipino, Peter Germonpré, Danilo Toni, et al.
Nature Reviews. Cardiology|July 20, 2023
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosisDiana A Gorog, Jose Luis Ferreiro, Ingo Ahrens, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
European Heart Journal|June 22, 2019
Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trialDániel Aradi, Lisa Gross, Dietmar Trenk, et al.
Pageof 20

Showing results (151-160 of 200) with videos related to

Sort By:
Pageof 20
Annals of Internal Medicine|July 21, 2020
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized TrialMaurizio Menichelli, Franz-Josef Neumann, Gjin Ndrepepa, et al.
European Heart Journal|October 26, 2018
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolismChristian Pristipino, Horst Sievert, Fabrizio D'Ascenzo, et al.
International Journal of Cardiology. Heart & Vasculature|July 14, 2021
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stentingLisa Riesinger, Claudia Strobl, David M Leistner, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 25, 2018
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolismChristian Pristipino, Horst Sievert, Fabrizio D'Ascenzo, et al.
Journal of the American College of Cardiology|March 7, 2015
Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart diseaseKimon Stamatelopoulos, Dirk Sibbing, Loukianos S Rallidis, et al.
Thrombosis and Haemostasis|November 28, 2022
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesTobias Koch, Shqipdona Lahu, J J Coughlan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 28, 2021
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditionsChristian Pristipino, Peter Germonpré, Danilo Toni, et al.
Nature Reviews. Cardiology|July 20, 2023
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosisDiana A Gorog, Jose Luis Ferreiro, Ingo Ahrens, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
European Heart Journal|June 22, 2019
Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trialDániel Aradi, Lisa Gross, Dietmar Trenk, et al.
Pageof 20